DENVER, April 21, 2026 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (the “Company” or “NBHC”) reported:   For the quarter(1)   For the quarter – adjusted(1)(2)  1Q26   4Q25   1Q25   1Q26   4Q25   1Q25Net income ($000’s) $ 20,793   $ 16,036   $ 24,231   $ 32,607   $ 22,748   $ 24,231Earnings per share – diluted $ 0.46   $ 0.42   $ 0.63   $ 0.72   $ 0.60   $ 0.63Return on average assets   0.70%     0.65%     0.99%     1.09%     0.92%     0.99%Return on average tangible assets(2)   0.79%     0.73%     1.09%     1.20%     1.02%     1.09%Return on average equity   5.02%     4.57%     7.42%     7.87%     6.48%     7.42%Return on average tangible common equity(2)   7.75%     6.58%     10.64%     11.79%     9.10%     10.64%                                                      (1)   Quarterly...

PROVIDENCE, R.I. , April 21, 2026 (GLOBE NEWSWIRE) — via IBN — Beeline Holdings, Inc. (NASDAQ: BLNE), the fast-growing digital mortgage platform redefining the path to homeownership, today announced it will host a stakeholder update call on the results of the first quarter of 2026 on Thursday, May 14, 2026, at 5:00 PM ET. The call will be hosted by Nick Liuzza, Chief Executive Officer, and Chris Moe, Chief Financial Officer, who will review the company’s performance and provide updates on ongoing initiatives. Call Details:Listen-only webcast:https://event.choruscall.com/mediaframe/webcast.html?webcastid=lhQu88bnToll-Free Dial-In (U.S.): 877-317-6789 International Dial-In: 412-317-6789About Beeline  Beeline Holdings, Inc. is a trailblazing mortgage fintech transforming the way people access property financing....

LITTLE ROCK, Ark., April 21, 2026 (GLOBE NEWSWIRE) — Bank OZK (the “Bank”) (Nasdaq: OZK) today announced that net income available to common stockholders for the first quarter of 2026 was $159.3 million, a 5.1% decrease from $167.9 million for the first quarter of 2025. Diluted earnings per common share (“EPS”) for the first quarter of 2026 were $1.44, a 2.0% decrease from $1.47 for the first quarter of 2025. George Gleason, Chairman and Chief Executive Officer, stated, “We are pleased to report our first quarter 2026 results, which provided a solid start to the year. Once again, our veteran team demonstrated our ability to effectively manage through a challenging macroeconomic and geopolitical environment and capitalize on opportunities. We believe we are well-positioned to continue to successfully execute on our strategic initiatives.” MANAGEMENT...

TORONTO, April 21, 2026 (GLOBE NEWSWIRE) — PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MDMA (MDXX class molecules), is pleased to have publicly filed its financial and operational results for the period ended February 28, 2026. All figures are reported in Canadian dollars. The Company’s full set of unaudited condensed interim consolidated financial statements for the quarter and accompanying management’s discussion and analysis can be accessed by visiting the Company’s website at www.PharmAla.ca and its profile page on SEDAR+ at www.sedarplus.ca. “PharmAla’s financial position continues to benefit from an operational focus by the Company’s management,” said Nick...

Net income of $21.8 million, or $1.12 per diluted share, for the three months ended March 31, 2026 compared to net income of $21.5 million, or $1.11 per diluted share, for the three months ended December 31, 2025; Return on average assets was 1.59% and return on average equity was 14.76% for the three months ended March 31, 2026, compared to 1.55% and 14.73%, respectively, for the three months ended December 31, 2025; Net interest margin, on a tax equivalent basis, was 3.90% in the first quarter of 2026 compared to 4.00% in the fourth quarter of 2025; Total loans increased by $40.6 million, or approximately 4% annualized, from December 31, 2025 to March 31, 2026; Deposits increased by $98.7 million from December 31, 2025 to March 31, 2026; borrowings decreased by $68.0 million from December 31, 2025 to March 31, 2026; Noninterest income...

LOS ANGELES, April 21, 2026 (GLOBE NEWSWIRE) — Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today reported financial results for the first quarter of 2026. Net income for the first quarter of 2026 was $22.6 million, or $0.75 per diluted share, compared with $21.2 million, or $0.70 per diluted share for the fourth quarter of 2025. The return on average assets for the first quarter was 1.18% and the return on average equity was 10.86%, compared with a return on average assets of 1.07% and a return on average equity of 10.14% for the fourth quarter of 2025. CEO Commentary“Hanmi delivered strong results in the first quarter, reflecting the effective execution of our growth strategy,” said Bonnie Lee, President and Chief Executive Officer. “We saw several positive trends, including...

Declares Cash Dividend of $0.30 per Share Payable on June 15, 2026 RENO, Nev., April 21, 2026 (GLOBE NEWSWIRE) — Monarch Casino & Resort, Inc. (Nasdaq: MCRI) (“Monarch” or “the Company”) today reported operating results for the first quarter ended March 31, 2026, as summarized below: ($ in thousands, except per share data and percentages)    Three Months Ended March 31,        2026     2025 IncreaseNet revenue   $ 136,550   $ 125,394 8.9%Net income   $ 27,592   $ 19,864 38.9%Adjusted EBITDA(1)   $ 48,951   $ 41,131 19.0%           Basic EPS   $ 1.55   $ 1.08 43.5%Diluted EPS   $ 1.52   $ 1.05 44.8%               (1)   Definitions, disclosures and reconciliations of non-GAAP financial information are included later in the release. CEO CommentJohn Farahi, Co-Chairman and Chief Executive Officer of...

IRVINE, Calif., April 21, 2026 (GLOBE NEWSWIRE) — Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended March 31, 2026 and raised its full year guidance for the year ending December 31, 2026. First Quarter 2026 Financial Highlights & Key MetricsNet sales of $27.6 million, up 57% compared to $17.6 million in the first quarter of 2025.Durable Medical Equipment (DME) channel net sales of $16.9 million, up 22% compared to $13.8 million in the first quarter of 2025. Pharmacy Benefit Plan (PBP) channel net sales of $10.7 million, up 181% compared to $3.8 million in the first quarter of 2025.Gross margin of 59.5%, up 864 basis points compared to 50.9% in the first quarter of 2025. New patient starts declined...